PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Eva-B Bröcker Selected Research
Bullous Pemphigoid (Pemphigoid)
11/2006
Localisation of bullous pemphigoid antigen 180 (BP180) in cultured human keratinocytes: functionally relevant modification by calcium.
01/2006
[Anti-laminin 5 mucous membrane pemphigoid]
12/2004
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
12/2003
The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane.
04/2002
Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
01/2002
Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
Articles by Research Topic
Disease
8
Melanoma (Melanoma, Malignant)
11/2007 - 01/2002
6
Bullous Pemphigoid (Pemphigoid)
11/2006 - 01/2002
4
Anaphylaxis (Anaphylactic Shock)
03/2008 - 04/2002
4
Hypersensitivity (Allergy)
03/2008 - 02/2005
3
Neoplasms (Cancer)
05/2006 - 01/2002
3
Neoplasm Metastasis (Metastasis)
02/2006 - 02/2003
1
Exanthema (Rash)
07/2007
1
Toxic Epidermal Necrolysis (Lyell's Syndrome)
03/2007
1
Vomiting
10/2006
1
Dermatitis
10/2006
1
Nausea
10/2006
1
Vitiligo
09/2005
1
Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
12/2004
1
Pemphigus (Pemphigus Vulgaris)
01/2004
1
Experimental Melanoma
12/2003
1
Infection
04/2002
1
Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
01/2002
1
Pemphigoid Gestationis (Herpes Gestationis)
01/2002
Drug/Important Bio-Agent (IBA)
4
Antigens
IBA
11/2006 - 04/2002
4
Autoantibodies
IBA
12/2004 - 01/2002
2
Immunoglobulin E (IgE)
IBA
03/2008 - 10/2006
2
Matrix Metalloproteinases
IBA
03/2005 - 12/2003
1
bevacizumab
FDA Link
11/2007
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2007
1
Cephalosporins (Cephalosporin Antibiotics)
IBA
07/2007
1
Penicillin V (Phenoxymethylpenicillin)
FDA Link
Generic
07/2007
1
clobutinol
IBA
03/2007
1
Methotrexate (Mexate)
FDA Link
Generic
03/2007
1
Calcium
IBA
11/2006
1
sodium metabisulfite (sodium pyrosulfite)
IBA
10/2006
1
Metoclopramide (Reglan)
FDA Link
Generic
10/2006
1
Vascular Endothelial Growth Factor Receptor-3 (Flt 4)
IBA
02/2006
1
kalinin
IBA
01/2006
1
Phosphotransferases (Kinase)
IBA
10/2005
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
10/2005
1
calcipotriene (calcipotriol)
FDA Link
Generic
09/2005
1
Heparin (Liquaemin)
FDA Link
Generic
02/2005
1
Pancreatic Elastase (Elastase)
IBA
12/2004
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
12/2004
1
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2004
1
Desmoglein 3
IBA
01/2004
1
Glycoproteins (Glycoprotein)
IBA
12/2003
1
Epinephrine (Adrenaline)
FDA Link
Generic
02/2003
1
Cisplatin (Platino)
FDA Link
Generic
02/2003
1
Dacarbazine (DIC)
FDA Link
Generic
10/2002
1
Interleukin-2 (IL2)
IBA
01/2002
Therapy/Procedure
1
Drug Therapy (Chemotherapy)
11/2007
1
Emergency Treatment
03/2007
1
Immunotherapy
05/2006